Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations

NCT01520051 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Asthma
Viral Infection

Interventions

DRUG: Mepolizumab
DRUG: Placebo

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborators

[object Object]
[object Object]